ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Prostate Cancer Drugs - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-1P7758
Home | Market Reports | Health| Men s Health
Global Prostate Cancer Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Prostate Cancer Drugs - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-1P7758
Report
November 2023
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Merck Group
Novartis
Amgen Inc
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals

Prostate Cancer Drugs - Market Size

The global Prostate Cancer Drugs market size is expected to reach US$ 10100 million by 2029, growing at a CAGR of 6.5% from 2023 to 2029.

Prostate Cancer Drugs - Market

Prostate Cancer Drugs - Market

The market is mainly driven by the significant applications of Prostate Cancer Drugs in various end use industries. The expanding demands from the Clinics, Hospitals and Others,, are propelling Prostate Cancer Drugs market. Hormonal Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Prostate Cancer Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Drugs covered in this report include AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis and Amgen, etc.
The global Prostate Cancer Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals

Scope of Prostate Cancer Drugs - Market Report

Report Metric Details
Report Name Prostate Cancer Drugs - Market
Forecasted market size in 2029 US$ 10100 million
CAGR 6.5%
Forecasted years 2023 - 2029
Global Prostate Cancer Drugs market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Drugs market, Segment by Type:
  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
Global Prostate Cancer Drugs market, by Application
  • Clinics
  • Hospitals
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Prostate Cancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Prostate Cancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Prostate Cancer Drugs - Market size in 2029?

Ans: The Prostate Cancer Drugs - Market size in 2029 will be US$ 10100 million.

What are the Application segmentation covered in the Prostate Cancer Drugs - Market report?

Ans: The Applications covered in the Prostate Cancer Drugs - Market report are Clinics, Hospitals, Others

What are the Type segmentation covered in the Prostate Cancer Drugs - Market report?

Ans: The Types covered in the Prostate Cancer Drugs - Market report are Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy

1 Prostate Cancer Drugs Market Overview
1.1 Prostate Cancer Drugs Product Overview
1.2 Prostate Cancer Drugs Market Segment by Type
1.2.1 Hormonal Therapy
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.3 Global Prostate Cancer Drugs Market Size by Type
1.3.1 Global Prostate Cancer Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Prostate Cancer Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Prostate Cancer Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prostate Cancer Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Prostate Cancer Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Prostate Cancer Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Prostate Cancer Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Prostate Cancer Drugs Sales Breakdown by Type (2018-2023)
2 Global Prostate Cancer Drugs Market Competition by Company
2.1 Global Top Players by Prostate Cancer Drugs Sales (2018-2023)
2.2 Global Top Players by Prostate Cancer Drugs Revenue (2018-2023)
2.3 Global Top Players by Prostate Cancer Drugs Price (2018-2023)
2.4 Global Top Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prostate Cancer Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Prostate Cancer Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Prostate Cancer Drugs Market
2.8 Key Manufacturers Prostate Cancer Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prostate Cancer Drugs Status and Outlook by Region
3.1 Global Prostate Cancer Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Prostate Cancer Drugs Historic Market Size by Region
3.2.1 Global Prostate Cancer Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Prostate Cancer Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Prostate Cancer Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Prostate Cancer Drugs Forecasted Market Size by Region
3.3.1 Global Prostate Cancer Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Prostate Cancer Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Prostate Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Prostate Cancer Drugs by Application
4.1 Prostate Cancer Drugs Market Segment by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Others
4.2 Global Prostate Cancer Drugs Market Size by Application
4.2.1 Global Prostate Cancer Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Prostate Cancer Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Prostate Cancer Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prostate Cancer Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Prostate Cancer Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Prostate Cancer Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Prostate Cancer Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Prostate Cancer Drugs Sales Breakdown by Application (2018-2023)
5 North America Prostate Cancer Drugs by Country
5.1 North America Prostate Cancer Drugs Historic Market Size by Country
5.1.1 North America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Prostate Cancer Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Prostate Cancer Drugs Sales in Value by Country (2018-2023)
5.2 North America Prostate Cancer Drugs Forecasted Market Size by Country
5.2.1 North America Prostate Cancer Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Prostate Cancer Drugs Sales in Value by Country (2024-2029)
6 Europe Prostate Cancer Drugs by Country
6.1 Europe Prostate Cancer Drugs Historic Market Size by Country
6.1.1 Europe Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Prostate Cancer Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Prostate Cancer Drugs Sales in Value by Country (2018-2023)
6.2 Europe Prostate Cancer Drugs Forecasted Market Size by Country
6.2.1 Europe Prostate Cancer Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Prostate Cancer Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Prostate Cancer Drugs by Region
7.1 Asia-Pacific Prostate Cancer Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Prostate Cancer Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Prostate Cancer Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Prostate Cancer Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Prostate Cancer Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Prostate Cancer Drugs Sales in Value by Region (2024-2029)
8 Latin America Prostate Cancer Drugs by Country
8.1 Latin America Prostate Cancer Drugs Historic Market Size by Country
8.1.1 Latin America Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Prostate Cancer Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Prostate Cancer Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Prostate Cancer Drugs Forecasted Market Size by Country
8.2.1 Latin America Prostate Cancer Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Prostate Cancer Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Prostate Cancer Drugs by Country
9.1 Middle East and Africa Prostate Cancer Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Prostate Cancer Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Prostate Cancer Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Prostate Cancer Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Prostate Cancer Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Prostate Cancer Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Prostate Cancer Drugs Products Offered
10.1.5 AbbVie Recent Development
10.2 Astellas Pharma
10.2.1 Astellas Pharma Company Information
10.2.2 Astellas Pharma Introduction and Business Overview
10.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
10.2.5 Astellas Pharma Recent Development
10.3 Astra Zeneca
10.3.1 Astra Zeneca Company Information
10.3.2 Astra Zeneca Introduction and Business Overview
10.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
10.3.5 Astra Zeneca Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Prostate Cancer Drugs Products Offered
10.5.5 Sanofi Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Merck Group
10.7.1 Merck Group Company Information
10.7.2 Merck Group Introduction and Business Overview
10.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Group Prostate Cancer Drugs Products Offered
10.7.5 Merck Group Recent Development
10.8 Novartis
10.8.1 Novartis Company Information
10.8.2 Novartis Introduction and Business Overview
10.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Novartis Prostate Cancer Drugs Products Offered
10.8.5 Novartis Recent Development
10.9 Amgen
10.9.1 Amgen Company Information
10.9.2 Amgen Introduction and Business Overview
10.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Amgen Prostate Cancer Drugs Products Offered
10.9.5 Amgen Recent Development
10.10 Bayer HealthCare
10.10.1 Bayer HealthCare Company Information
10.10.2 Bayer HealthCare Introduction and Business Overview
10.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
10.10.5 Bayer HealthCare Recent Development
10.11 Ferring Pharmaceutical
10.11.1 Ferring Pharmaceutical Company Information
10.11.2 Ferring Pharmaceutical Introduction and Business Overview
10.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Products Offered
10.11.5 Ferring Pharmaceutical Recent Development
10.12 Janssen Pharmaceuticals
10.12.1 Janssen Pharmaceuticals Company Information
10.12.2 Janssen Pharmaceuticals Introduction and Business Overview
10.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Products Offered
10.12.5 Janssen Pharmaceuticals Recent Development
10.13 Endo Pharmaceuticals
10.13.1 Endo Pharmaceuticals Company Information
10.13.2 Endo Pharmaceuticals Introduction and Business Overview
10.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Products Offered
10.13.5 Endo Pharmaceuticals Recent Development
10.14 BMS
10.14.1 BMS Company Information
10.14.2 BMS Introduction and Business Overview
10.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 BMS Prostate Cancer Drugs Products Offered
10.14.5 BMS Recent Development
10.15 Takeda Pharmaceuticals
10.15.1 Takeda Pharmaceuticals Company Information
10.15.2 Takeda Pharmaceuticals Introduction and Business Overview
10.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Products Offered
10.15.5 Takeda Pharmaceuticals Recent Development
10.16 Northwest Biotherapeutics
10.16.1 Northwest Biotherapeutics Company Information
10.16.2 Northwest Biotherapeutics Introduction and Business Overview
10.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Products Offered
10.16.5 Northwest Biotherapeutics Recent Development
10.17 Teva Pharmaceutical
10.17.1 Teva Pharmaceutical Company Information
10.17.2 Teva Pharmaceutical Introduction and Business Overview
10.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Teva Pharmaceutical Prostate Cancer Drugs Products Offered
10.17.5 Teva Pharmaceutical Recent Development
10.18 Boehringer Ingelheim
10.18.1 Boehringer Ingelheim Company Information
10.18.2 Boehringer Ingelheim Introduction and Business Overview
10.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Boehringer Ingelheim Prostate Cancer Drugs Products Offered
10.18.5 Boehringer Ingelheim Recent Development
10.19 Foresee Pharmaceuticals
10.19.1 Foresee Pharmaceuticals Company Information
10.19.2 Foresee Pharmaceuticals Introduction and Business Overview
10.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Products Offered
10.19.5 Foresee Pharmaceuticals Recent Development
10.20 Tokai Pharmaceuticals
10.20.1 Tokai Pharmaceuticals Company Information
10.20.2 Tokai Pharmaceuticals Introduction and Business Overview
10.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Products Offered
10.20.5 Tokai Pharmaceuticals Recent Development
10.21 Spectrum Pharmaceuticals
10.21.1 Spectrum Pharmaceuticals Company Information
10.21.2 Spectrum Pharmaceuticals Introduction and Business Overview
10.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Products Offered
10.21.5 Spectrum Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prostate Cancer Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prostate Cancer Drugs Industrial Chain Analysis
11.4 Prostate Cancer Drugs Market Dynamics
11.4.1 Prostate Cancer Drugs Industry Trends
11.4.2 Prostate Cancer Drugs Market Drivers
11.4.3 Prostate Cancer Drugs Market Challenges
11.4.4 Prostate Cancer Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prostate Cancer Drugs Distributors
12.3 Prostate Cancer Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Merck Group
Novartis
Amgen Inc
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
List of Tables
    Table 1. Major Company of Hormonal Therapy
    Table 2. Major Company of Chemotherapy
    Table 3. Major Company of Immunotherapy
    Table 4. Major Company of Targeted Therapy
    Table 5. Global Prostate Cancer Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Prostate Cancer Drugs Sales by Type (2018-2023) & (K MT)
    Table 7. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Prostate Cancer Drugs Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Prostate Cancer Drugs Market Share in Value by Type (2018-2023)
    Table 10. Global Prostate Cancer Drugs Price by Type (2018-2023) & (USD/MT)
    Table 11. Global Prostate Cancer Drugs Sales by Type (2024-2029) & (K MT)
    Table 12. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Prostate Cancer Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Prostate Cancer Drugs Price by Type (2024-2029) & (USD/MT)
    Table 16. North America Prostate Cancer Drugs Sales by Type (2018-2023) & (K MT)
    Table 17. North America Prostate Cancer Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Prostate Cancer Drugs Sales (K MT) by Type (2018-2023)
    Table 19. Europe Prostate Cancer Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Prostate Cancer Drugs Sales (K MT) by Type (2018-2023)
    Table 21. Asia-Pacific Prostate Cancer Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Prostate Cancer Drugs Sales (K MT) by Type (2018-2023)
    Table 23. Latin America Prostate Cancer Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Prostate Cancer Drugs Sales (K MT) by Type (2018-2023)
    Table 25. Middle East and Africa Prostate Cancer Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Prostate Cancer Drugs Sales by Company (2018-2023) & (K MT)
    Table 27. Global Prostate Cancer Drugs Sales Share by Company (2018-2023)
    Table 28. Global Prostate Cancer Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Prostate Cancer Drugs Revenue Share by Company (2018-2023)
    Table 30. Global Market Prostate Cancer Drugs Price by Company (2018-2023) & (USD/MT)
    Table 31. Global Prostate Cancer Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2022)
    Table 34. Date of Key Manufacturers Enter into Prostate Cancer Drugs Market
    Table 35. Key Manufacturers Prostate Cancer Drugs Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Prostate Cancer Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Prostate Cancer Drugs Sales by Region (2018-2023) & (K MT)
    Table 39. Global Prostate Cancer Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Prostate Cancer Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Prostate Cancer Drugs Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 43. Global Prostate Cancer Drugs Sales by Region (2024-2029) & (K MT)
    Table 44. Global Prostate Cancer Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Prostate Cancer Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Prostate Cancer Drugs Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
    Table 48. Global Prostate Cancer Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Prostate Cancer Drugs Sales by Application (2018-2023) & (K MT)
    Table 50. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2018-2023)
    Table 51. Global Prostate Cancer Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 52. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2018-2023)
    Table 53. Global Prostate Cancer Drugs Price by Application (2018-2023) & (USD/MT)
    Table 54. Global Prostate Cancer Drugs Sales by Application (2024-2029) & (K MT)
    Table 55. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2024-2029)
    Table 56. Global Prostate Cancer Drugs Sales by Application (2024-2029) & (US$ Million)
    Table 57. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2024-2029)
    Table 58. Global Prostate Cancer Drugs Price by Application (2024-2029) & (USD/MT)
    Table 59. North America Prostate Cancer Drugs Sales by Application (2018-2023) (K MT)
    Table 60. North America Prostate Cancer Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 61. Europe Prostate Cancer Drugs Sales by Application (2018-2023) (K MT)
    Table 62. Europe Prostate Cancer Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Prostate Cancer Drugs Sales by Application (2018-2023) (K MT)
    Table 64. Asia-Pacific Prostate Cancer Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 65. Latin America Prostate Cancer Drugs Sales by Application (2018-2023) (K MT)
    Table 66. Latin America Prostate Cancer Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Prostate Cancer Drugs Sales by Application (2018-2023) (K MT)
    Table 68. Middle East and Africa Prostate Cancer Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 69. North America Prostate Cancer Drugs Sales by Country (2018-2023) & (K MT)
    Table 70. North America Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Prostate Cancer Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Prostate Cancer Drugs Sales by Country (2024-2029) & (K MT)
    Table 74. North America Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Prostate Cancer Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Prostate Cancer Drugs Sales by Country (2018-2023) & (K MT)
    Table 78. Europe Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Prostate Cancer Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Prostate Cancer Drugs Sales by Country (2024-2029) & (K MT)
    Table 82. Europe Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Prostate Cancer Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Prostate Cancer Drugs Sales by Region (2018-2023) & (K MT)
    Table 86. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Prostate Cancer Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Prostate Cancer Drugs Sales by Region (2024-2029) & (K MT)
    Table 90. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Prostate Cancer Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Prostate Cancer Drugs Sales by Country (2018-2023) & (K MT)
    Table 94. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Prostate Cancer Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Prostate Cancer Drugs Sales by Country (2024-2029) & (K MT)
    Table 98. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Prostate Cancer Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Prostate Cancer Drugs Sales by Country (2018-2023) & (K MT)
    Table 102. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Prostate Cancer Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Prostate Cancer Drugs Sales by Country (2024-2029) & (K MT)
    Table 106. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Prostate Cancer Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Country (2024-2029)
    Table 109. AbbVie Company Information
    Table 110. AbbVie Introduction and Business Overview
    Table 111. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 112. AbbVie Prostate Cancer Drugs Product
    Table 113. AbbVie Recent Development
    Table 114. Astellas Pharma Company Information
    Table 115. Astellas Pharma Introduction and Business Overview
    Table 116. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 117. Astellas Pharma Prostate Cancer Drugs Product
    Table 118. Astellas Pharma Recent Development
    Table 119. Astra Zeneca Company Information
    Table 120. Astra Zeneca Introduction and Business Overview
    Table 121. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 122. Astra Zeneca Prostate Cancer Drugs Product
    Table 123. Astra Zeneca Recent Development
    Table 124. Johnson & Johnson Company Information
    Table 125. Johnson & Johnson Introduction and Business Overview
    Table 126. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 127. Johnson & Johnson Prostate Cancer Drugs Product
    Table 128. Johnson & Johnson Recent Development
    Table 129. Sanofi Company Information
    Table 130. Sanofi Introduction and Business Overview
    Table 131. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 132. Sanofi Prostate Cancer Drugs Product
    Table 133. Sanofi Recent Development
    Table 134. GlaxoSmithKline Company Information
    Table 135. GlaxoSmithKline Introduction and Business Overview
    Table 136. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 137. GlaxoSmithKline Prostate Cancer Drugs Product
    Table 138. GlaxoSmithKline Recent Development
    Table 139. Merck Group Company Information
    Table 140. Merck Group Introduction and Business Overview
    Table 141. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 142. Merck Group Prostate Cancer Drugs Product
    Table 143. Merck Group Recent Development
    Table 144. Novartis Company Information
    Table 145. Novartis Introduction and Business Overview
    Table 146. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 147. Novartis Prostate Cancer Drugs Product
    Table 148. Novartis Recent Development
    Table 149. Amgen Company Information
    Table 150. Amgen Introduction and Business Overview
    Table 151. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 152. Amgen Prostate Cancer Drugs Product
    Table 153. Amgen Recent Development
    Table 154. Bayer HealthCare Company Information
    Table 155. Bayer HealthCare Introduction and Business Overview
    Table 156. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 157. Bayer HealthCare Prostate Cancer Drugs Product
    Table 158. Bayer HealthCare Recent Development
    Table 159. Ferring Pharmaceutical Company Information
    Table 160. Ferring Pharmaceutical Introduction and Business Overview
    Table 161. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 162. Ferring Pharmaceutical Prostate Cancer Drugs Product
    Table 163. Ferring Pharmaceutical Recent Development
    Table 164. Janssen Pharmaceuticals Company Information
    Table 165. Janssen Pharmaceuticals Introduction and Business Overview
    Table 166. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 167. Janssen Pharmaceuticals Prostate Cancer Drugs Product
    Table 168. Janssen Pharmaceuticals Recent Development
    Table 169. Endo Pharmaceuticals Company Information
    Table 170. Endo Pharmaceuticals Introduction and Business Overview
    Table 171. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 172. Endo Pharmaceuticals Prostate Cancer Drugs Product
    Table 173. Endo Pharmaceuticals Recent Development
    Table 174. BMS Company Information
    Table 175. BMS Introduction and Business Overview
    Table 176. BMS Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 177. BMS Prostate Cancer Drugs Product
    Table 178. BMS Recent Development
    Table 179. Takeda Pharmaceuticals Company Information
    Table 180. Takeda Pharmaceuticals Introduction and Business Overview
    Table 181. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 182. Takeda Pharmaceuticals Prostate Cancer Drugs Product
    Table 183. Takeda Pharmaceuticals Recent Development
    Table 184. Northwest Biotherapeutics Company Information
    Table 185. Northwest Biotherapeutics Introduction and Business Overview
    Table 186. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 187. Northwest Biotherapeutics Prostate Cancer Drugs Product
    Table 188. Northwest Biotherapeutics Recent Development
    Table 189. Teva Pharmaceutical Company Information
    Table 190. Teva Pharmaceutical Introduction and Business Overview
    Table 191. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 192. Teva Pharmaceutical Prostate Cancer Drugs Product
    Table 193. Teva Pharmaceutical Recent Development
    Table 194. Boehringer Ingelheim Company Information
    Table 195. Boehringer Ingelheim Introduction and Business Overview
    Table 196. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 197. Boehringer Ingelheim Prostate Cancer Drugs Product
    Table 198. Boehringer Ingelheim Recent Development
    Table 199. Foresee Pharmaceuticals Company Information
    Table 200. Foresee Pharmaceuticals Introduction and Business Overview
    Table 201. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 202. Foresee Pharmaceuticals Prostate Cancer Drugs Product
    Table 203. Foresee Pharmaceuticals Recent Development
    Table 204. Tokai Pharmaceuticals Company Information
    Table 205. Tokai Pharmaceuticals Introduction and Business Overview
    Table 206. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 207. Tokai Pharmaceuticals Prostate Cancer Drugs Product
    Table 208. Tokai Pharmaceuticals Recent Development
    Table 209. Spectrum Pharmaceuticals Company Information
    Table 210. Spectrum Pharmaceuticals Introduction and Business Overview
    Table 211. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 212. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
    Table 213. Spectrum Pharmaceuticals Recent Development
    Table 214. Key Raw Materials Lists
    Table 215. Raw Materials Key Suppliers Lists
    Table 216. Prostate Cancer Drugs Market Trends
    Table 217. Prostate Cancer Drugs Market Drivers
    Table 218. Prostate Cancer Drugs Market Challenges
    Table 219. Prostate Cancer Drugs Market Restraints
    Table 220. Prostate Cancer Drugs Distributors List
    Table 221. Prostate Cancer Drugs Downstream Customers
    Table 222. Research Programs/Design for This Report
    Table 223. Key Data Information from Secondary Sources
    Table 224. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prostate Cancer Drugs Product Picture
    Figure 2. Global Prostate Cancer Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Prostate Cancer Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Prostate Cancer Drugs Sales Status and Outlook (2018-2029) & (K MT)
    Figure 5. Product Picture of Hormonal Therapy
    Figure 6. Global Hormonal Therapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 7. Product Picture of Chemotherapy
    Figure 8. Global Chemotherapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 9. Product Picture of Immunotherapy
    Figure 10. Global Immunotherapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 11. Product Picture of Targeted Therapy
    Figure 12. Global Targeted Therapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 13. Global Prostate Cancer Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Prostate Cancer Drugs Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
    Figure 16. North America Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
    Figure 17. Europe Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Drugs Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Drugs Revenue in 2022
    Figure 27. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Clinics
    Figure 29. Global Clinics Sales YoY Growth (2018-2029) & (K MT)
    Figure 30. Product Picture of Hospitals
    Figure 31. Global Hospitals Sales YoY Growth (2018-2029) & (K MT)
    Figure 32. Product Picture of Others
    Figure 33. Global Others Sales YoY Growth (2018-2029) & (K MT)
    Figure 34. Global Prostate Cancer Drugs Sales by Application (2018-2029) & (US$ Million)
    Figure 35. Global Prostate Cancer Drugs Sales Market Share by Application in 2022 & 2029
    Figure 36. North America Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
    Figure 37. North America Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
    Figure 38. Europe Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
    Figure 39. Europe Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
    Figure 40. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
    Figure 41. Asia-Pacific Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
    Figure 42. Latin America Prostate Cancer Drugs Sales Market Share in Volume by Application in 2022
    Figure 43. Latin America Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
    Figure 44. Middle East and Africa Prostate Cancer Drugs Sales Market Share in Value by Application in 2022
    Figure 45. Key Raw Materials Price
    Figure 46. Prostate Cancer Drugs Manufacturing Cost Structure
    Figure 47. Prostate Cancer Drugs Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions